PL380448A1 - Środek do leczenia dominującego zespołu drażliwego jelita grubego typu biegunkowego - Google Patents

Środek do leczenia dominującego zespołu drażliwego jelita grubego typu biegunkowego

Info

Publication number
PL380448A1
PL380448A1 PL380448A PL38044805A PL380448A1 PL 380448 A1 PL380448 A1 PL 380448A1 PL 380448 A PL380448 A PL 380448A PL 38044805 A PL38044805 A PL 38044805A PL 380448 A1 PL380448 A1 PL 380448A1
Authority
PL
Poland
Prior art keywords
diarrhea
therapeutic agent
bowel syndrome
irritable bowel
type irritable
Prior art date
Application number
PL380448A
Other languages
English (en)
Inventor
Akito Nishida
Akira Niwa
Yutaka Atsuta
Original Assignee
Astellas Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2004/000896 external-priority patent/WO2004066998A1/ja
Priority claimed from PCT/JP2004/006657 external-priority patent/WO2005073220A1/ja
Application filed by Astellas Pharma Inc. filed Critical Astellas Pharma Inc.
Publication of PL380448A1 publication Critical patent/PL380448A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL380448A 2004-01-30 2005-01-27 Środek do leczenia dominującego zespołu drażliwego jelita grubego typu biegunkowego PL380448A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2004/000896 WO2004066998A1 (ja) 2003-01-31 2004-01-30 安定な経口用固形医薬組成物
PCT/JP2004/006657 WO2005073220A1 (ja) 2004-01-30 2004-05-12 下痢型過敏性腸症候群治療剤

Publications (1)

Publication Number Publication Date
PL380448A1 true PL380448A1 (pl) 2007-02-05

Family

ID=39855141

Family Applications (1)

Application Number Title Priority Date Filing Date
PL380448A PL380448A1 (pl) 2004-01-30 2005-01-27 Środek do leczenia dominującego zespołu drażliwego jelita grubego typu biegunkowego

Country Status (3)

Country Link
EP (1) EP1559446B1 (pl)
AT (1) ATE516061T1 (pl)
PL (1) PL380448A1 (pl)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
US6566369B2 (en) * 2000-07-26 2003-05-20 Solvay Pharmaceuticals Gmbh Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients

Also Published As

Publication number Publication date
ATE516061T1 (de) 2011-07-15
EP1559446B1 (en) 2011-07-13
HK1090561A1 (en) 2006-12-29
EP1559446A1 (en) 2005-08-03

Similar Documents

Publication Publication Date Title
IL189212A0 (en) Therapeutic agent for diabetes
IL192369A0 (en) Therapeutic agent for diabetes
ZA200606154B (en) Pharmaceutical composition comprising pimobendan
GB0521139D0 (en) Therapeutic agent
GB0615545D0 (en) Therapeutic agent
HUE041365T2 (hu) Demodikózis elleni szer
EP1872795A4 (en) THERAPEUTIC AGENT AGAINST IRRITATION SYNDROME
GB0425658D0 (en) Immunotherapeutic agent
EP1844792A4 (en) THERAPEUTIC AGENT AGAINST OBSTIPATION
GB0413818D0 (en) Dosage unit
EP1953164A4 (en) THERAPEUTIC OR PROPHYLACTIC AGENT AGAINST FUNCTIONAL ENDURANCE
GB0418756D0 (en) Supports
PL380448A1 (pl) Środek do leczenia dominującego zespołu drażliwego jelita grubego typu biegunkowego
AU2005209112A1 (en) Therapeutic agent for diarrhea-type irritable bowel syndrome
GB0508153D0 (en) Therapeutic agent
EP1840200A4 (en) DESINCRUSTANT AGENT
GB0400310D0 (en) Anti-incrustation agent
GB0408959D0 (en) Therapeutic agent
GB0516732D0 (en) Therapeutic agent
EP1712219A4 (en) AGENT DECREASING WRINKLES
PL368096A1 (pl) Środek zwilżająco-piorący
ZA200806143B (en) Therapeutic agent for diabetes
AU302150S (en) Bracket
AU156236S (en) Bracket
GB0601818D0 (en) Therapeutic agent

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)